Updates are available New edition dated 2021-01-28

Click to view New edition: https://doi.org/10.29328/journal.jprr.1001018

Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC

Crossref DOI link: https://doi.org/10.29328/journal.jprr.1001018

Published Online: 2021-01-28

Published Print: 2021-01-28

Update policy: https://doi.org/10.29328/journal/jprr

About CrossMark